Practice Areas
Simon is a partner in Cooley’s life sciences practice advising on mergers & acquisitions (public and private), initial public offerings and other capital-raising transactions, and venture and growth capital investments. Simon has extensive experience in advising companies at all stages of their development, as well as counseling investors and investment banks. He has represented a wide range of clients in the life sciences, technology and sustainable technology industries.
Simon’s representative experience includes advising:
* Oxford Biomedica PLC (LSE) on its £60 million placing of ordinary shares
* Medicxi and other investors in the sale of Vicebio to Sanofi for up to $1.6 billion
* EsoBiotec SA on its sale to AstraZeneca for up to $1 billion
* Araris Biotech on its sale to Taiho Pharmaceutical for up to $1.14 billion
* Kheiron Medical Technologies Limited on its sale to DeepHealth